Indium (111In) biciromab
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | Fab' fragment |
Source | Mouse |
Target | Fibrin II, beta chain |
Clinical data | |
Trade names | FibriScint |
Pregnancy category |
|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG | |
(what is this?) (verify) |
Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.[1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,[2] but was withdrawn during clinical trials.[3]
References
- ^ King DJ, Adair JR (March 1999). "Recombinant antibodies for the diagnosis and therapy of human diseases". Current Opinion in Drug Discovery & Development. 2 (2): 110–7. PMID 19649936.
- ^ "Centocor Ortho Biotech Products, L.P." Answers.com.
- ^ "Centocor withdraws imaging agent applications". DiagnosticImaging.com.
Categories:
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- Janssen Biotech
- All stub articles
- Monoclonal antibody stubs